Bio-Techne
TECH
#1331
Rank
$13.19 B
Marketcap
$83.75
Share price
0.30%
Change (1 day)
3.29%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Operating Margin for Bio-Techne (TECH)

Operating Margin as of May 2024 (TTM): 27.25%

According to Bio-Techne's latest financial reports and stock price the company's current Operating Margin is 27.25%. At the end of 2022 the company had an Operating Margin of 27.26%.

Operating Margin history for Bio-Techne from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202227.26%71.28%
202115.92%-57.48%
202037.43%138.57%
201915.69%-19.91%
201819.59%-2.54%
201720.10%-31.99%
201629.55%-13.3%
201534.09%-24.44%
201445.11%-12.8%
201351.73%0.33%
201251.56%-9.38%
201156.90%-2.15%
201058.15%-1.21%
200958.86%-1.5%
200859.76%3.58%
200757.69%5.16%
200654.86%-1.87%
200555.91%9.23%
200451.19%6.71%
200347.97%66.39%
200228.83%-30.44%
200141.44%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
14.17%-48.00%๐Ÿ‡บ๐Ÿ‡ธ USA
9.46%-65.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-1.37%-105.03%๐Ÿ‡บ๐Ÿ‡ธ USA
26.34%-3.34%๐Ÿ‡บ๐Ÿ‡ธ USA
23.93%-12.18%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-43.44%-259.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-19.26%-170.68%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.